Global Insulin Syringes Market 2022-2026: Rising Rates of Diabetes Worldwide Driving 4.69% Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 7, 2022--

The "Global Insulin Syringes Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.

The insulin syringes market is poised to grow by $ 408.67 mn during 2022-2026, accelerating at a CAGR of 4.69% during the forecast period. The report on the insulin syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, favorable government initiatives, and the availability of diabetes self-management education programs.

The insulin syringes market analysis includes type segment and geographic landscape.

The insulin syringes market is segmented as below:

By Type

• Type 2 diabetes
• Type 1 diabetes

By Geographical Landscape

• North America
• Europe
• APAC
• South America
• Middle East and Africa

This study identifies the increase in awareness programs for diabetes as one of the prime reasons driving the insulin syringes market growth during the next few years. Also, rising strategic partnerships to boost sales of insulin syringes and increasing focus on smart insulin syringes will lead to sizable demand in the market.

The report on the insulin syringes market covers the following areas:

• Insulin syringes market sizing
• Insulin syringes market forecast
• Insulin syringes market industry analysis

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Disease Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

Companies Mentioned

• AdvaCare Pharma
• ASP Healthcare Pty Ltd.
• Avantor Inc.
• B. Braun SE
• Becton Dickinson and Co.
• Cardinal Health Inc
• CODAN Medizinische Gerate GmbH and Co KG
• Gerresheimer AG
• Healthwarehouse.com Inc.
• Hi-Tech Medics Pvt Ltd.
• Hindustan Syringes and Medical Devices Ltd.
• LAC Healthcare Solutions
• Nipro Corp.
• Novo Nordisk AS
• Poly Medicure Ltd.
• SCHOTT AG
• Smiths Group Plc
• Terumo Corp.
• Thermo Fisher Scientific Inc.
• UltiMed Inc.

For more information about this report visit https://www.researchandmarkets.com/r/7q02ku

View source version on businesswire.com:https://www.businesswire.com/news/home/20221107005770/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: DIABETES PHARMACEUTICAL HEALTH MEDICAL SUPPLIES

SOURCE: Research and Markets

Copyright Business Wire 2022.